| scholarly article | Q13442814 |
| P50 | author | Chikara Sato | Q58883334 |
| P2093 | author name string | Hideko Inanaga | |
| Takuo Osawa | |||
| Tomoyuki Numata | |||
| P433 | issue | 3 | |
| P921 | main subject | CRISPR | Q412563 |
| crystal structure | Q895901 | ||
| P304 | page(s) | 418-430 | |
| P577 | publication date | 2015-04-23 | |
| P1433 | published in | Molecular Cell | Q3319468 |
| P1476 | title | Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog | |
| P478 | volume | 58 |
| Q35735544 | A Conserved Structural Chassis for Mounting Versatile CRISPR RNA-Guided Immune Responses |
| Q58708478 | A Type III-B Cmr effector complex catalyzes the synthesis of cyclic oligoadenylate second messengers by cooperative substrate binding |
| Q40420402 | A type III-B CRISPR-Cas effector complex mediating massive target DNA destruction |
| Q33660852 | An updated evolutionary classification of CRISPR-Cas systems |
| Q34509196 | Biology and Applications of CRISPR Systems: Harnessing Nature's Toolbox for Genome Engineering |
| Q36603869 | Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR-Cas system |
| Q58568511 | CRISPR-Based Technologies: Impact of RNA-Targeting Systems |
| Q64085639 | CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool |
| Q90883784 | CRISPR-mediated gene silencing reveals involvement of the archaeal S-layer in cell division and virus infection |
| Q94923711 | Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase |
| Q98575566 | Chemistry of Class 1 CRISPR-Cas effectors: binding, editing, and regulation |
| Q47104208 | Cmr1 enables efficient RNA and DNA interference of a III-B CRISPR-Cas system by binding to target RNA and crRNA. |
| Q39395687 | Conformational regulation of CRISPR-associated nucleases |
| Q64981879 | Coupling of ssRNA cleavage with DNase activity in type III-A CRISPR-Csm revealed by cryo-EM and biochemistry. |
| Q41922787 | Cryo-EM Structures Reveal Mechanism and Inhibition of DNA Targeting by a CRISPR-Cas Surveillance Complex |
| Q93252152 | Cryo-EM structure of Type III-A CRISPR effector complex |
| Q26783837 | Current and future prospects for CRISPR-based tools in bacteria |
| Q37418237 | DNA Targeting by a Minimal CRISPR RNA-Guided Cascade |
| Q34536517 | Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems |
| Q36256836 | Diversity and evolution of class 2 CRISPR-Cas systems |
| Q90025185 | Dynamics of Cas10 Govern Discrimination between Self and Non-self in Type III CRISPR-Cas Immunity |
| Q40628722 | Efficient CRISPR-Mediated Post-Transcriptional Gene Silencing in a Hyperthermophilic Archaeon Using Multiplexed crRNA Expression. |
| Q26740457 | Evolutionary Ecology of Prokaryotic Immune Mechanisms |
| Q27468936 | Exaptive origins of regulated mRNA decay in eukaryotes |
| Q40053915 | Guide-bound structures of an RNA-targeting A-cleaving CRISPR-Cas13a enzyme. |
| Q90298756 | Harnessing "A Billion Years of Experimentation": The Ongoing Exploration and Exploitation of CRISPR-Cas Immune Systems |
| Q45982664 | How bacteria control the CRISPR-Cas arsenal. |
| Q31147206 | Mg2+ ions: do they bind to nucleobase nitrogens? |
| Q46133715 | Molecular determinants for CRISPR RNA maturation in the Cas10-Csm complex and roles for non-Cas nucleases |
| Q38667891 | Multiple nucleic acid cleavage modes in divergent type III CRISPR systems |
| Q41628220 | Purification, crystallization, crystallographic analysis and phasing of the CRISPR-associated protein Csm2 from Thermotoga maritima |
| Q48340130 | RNA activation-independent DNA targeting of the Type III CRISPR-Cas system by a Csm complex. |
| Q36257710 | RNA and DNA Targeting by a Reconstituted Thermus thermophilus Type III-A CRISPR-Cas System |
| Q89659346 | RNA-Targeting CRISPR-Cas Systems and Their Applications |
| Q36603874 | RNA-activated DNA cleavage by the Type III-B CRISPR-Cas effector complex |
| Q90556101 | Regulation of the RNA and DNA nuclease activities required for Pyrococcus furiosus Type III-B CRISPR-Cas immunity |
| Q55436015 | Shooting the messenger: RNA-targetting CRISPR-Cas systems. |
| Q102369172 | Structural basis for assembly of non-canonical small subunits into type I-C Cascade |
| Q27703134 | Structural basis for dimer formation of the CRISPR-associated protein Csm2 of Thermotoga maritima |
| Q102388739 | Structural basis for inhibition of an archaeal CRISPR-Cas type I-D large subunit by an anti-CRISPR protein |
| Q64230158 | Structural organization of a Type III-A CRISPR effector subcomplex determined by X-ray crystallography and cryo-EM |
| Q38878360 | Structure Reveals Mechanisms of Viral Suppressors that Intercept a CRISPR RNA-Guided Surveillance Complex |
| Q90021362 | Structure Studies of the CRISPR-Csm Complex Reveal Mechanism of Co-transcriptional Interference |
| Q52425186 | Structure of Csm2 elucidates the relationship between small subunits of CRISPR-Cas effector complexes. |
| Q91665478 | Target preference of Type III-A CRISPR-Cas complexes at the transcription bubble |
| Q51148515 | The Biology of CRISPR-Cas: Backward and Forward. |
| Q59357210 | The ribonuclease activity of Csm6 is required for anti-plasmid immunity by Type III-A CRISPR-Cas systems |
| Q90025180 | Type III-A CRISPR-Cas Csm Complexes: Assembly, Periodic RNA Cleavage, DNase Activity Regulation, and Autoimmunity |
Search more.